In vitro expanded NK cells combined with rituximab can efficiently lyse autologous B-CLL cells and overcome the natural resistance to NK cell mediated killing.

被引：0

作者：

Broady, R

Golay, J

Gramigna, R

Facchinetti, V

Borleri, G

Salvi, A

Barbui, T

Introna, M

Rambaldi, A

机构：

[1] Osped Riuniti Bergamo, Div Hematol, I-24100 Bergamo, Italy

[2] Ist Ric Farmacol Mario Negri, Lab Mol Immunohematol, Milan, Italy

来源：

BLOOD | 2002年 / 100卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3172

引用

页码：803A / 803A

页数：1

共 50 条

[1] Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy
Veuillen, Caroline
Aurran-Schleinitz, Therese
Castellano, Remy
Rey, Jerome
Mallet, Francoise
Orlanducci, Florence
Pouyet, Laurent
Just-Landi, Sylvaine
Coso, Diane
Ivanov, Vadim
Carcopino, Xavier
Bouabdallah, Reda
Collette, Yves
Fauriat, Cyril
Olive, Daniel
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (03) : 632 - 646
[2] Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy
Caroline Veuillen
Thérèse Aurran-Schleinitz
Rémy Castellano
Jérôme Rey
Françoise Mallet
Florence Orlanducci
Laurent Pouyet
Sylvaine Just-Landi
Diane Coso
Vadim Ivanov
Xavier Carcopino
Réda Bouabdallah
Yves Collette
Cyril Fauriat
Daniel Olive
Journal of Clinical Immunology, 2012, 32 : 632 - 646
[3] Treatment of MCL Cells with Combined Rituximab and Lenalidomide Enhances NK-Mediated Synapse Formation and Cell Killing.
Gaidarova, Svetlana
Corral, Laura G.
Glezer, Emilia
Schafer, Peter H.
Lopez-Girona, Antonia
BLOOD, 2009, 114 (22) : 673 - 673
[4] IL-21-Expanded NK Cells As Autologous Cell Therapy for CLL
Lance, Jennie Rachel
Yano, Max
Mo, Xiaokui
Lee, Dean Anthony
Muthusamy, Natarajan
Byrd, John C.
BLOOD, 2019, 134
[5] Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
Tania Calvo
Chantal Reina-Ortiz
David Giraldos
María Gascón
Daniel Woods
Judit Asenjo
Joaquín Marco-Brualla
Gemma Azaceta
Isabel Izquierdo
Luis Palomera
Diego Sánchez-Martínez
Isabel Marzo
Javier Naval
Carlos Vilches
Martín Villalba
Alberto Anel
Scientific Reports, 10
[6] Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
Calvo, Tania
Reina-Ortiz, Chantal
Giraldos, David
Gascon, Maria
Woods, Daniel
Asenjo, Judit
Marco-Brualla, Joaquin
Azaceta, Gemma
Izquierdo, Isabel
Palomera, Luis
Sanchez-Martinez, Diego
Marzo, Isabel
Naval, Javier
Vilches, Carlos
Villalba, Martin
Anel, Alberto
SCIENTIFIC REPORTS, 2020, 10 (01)
[7] NK CELL (FROM PRIMARY NK CELL CULTURES) MEDIATED KILLING OF MULTIPLE MYELOMA CELLS IN VITRO
Martin, T.
Binder, Christian
Hildebrandt, Y.
Ey, C. Giff
Jungk, K.
Eiermann, T. Heinrich
Sierich, H.
Kroeger, N.
BONE MARROW TRANSPLANTATION, 2014, 49 : S153 - S153
[8] NK cell killing of autologous cells transduced with a neomycin resistance gene.
Albi, N
Ruggeri, L
Liberatore, C
Grignani, F
Velardi, A
BLOOD, 1996, 88 (10) : 629 - 629
[9] Treatment of B-CLL cells with bortezomib and rituximab reduces cell viability in vitro
Lewintre, EJ
Sarsotti, E
Terol, MJ
Benet, I
Martinez-Climent, JA
Garcia-Conde, J
BLOOD, 2004, 104 (11) : 765A - 766A
[10] NATURAL KILLER CELL (FROM PRIMARY NK CELL CULTURES) MEDIATED KILLING OF MULTIPLE MYELOMA CELLS IN VITRO
Binder, Thomas M. C.
Hildebrandt, York
Giffey, Christian
Jungk, Karla
Eiermann, Thomas H.
Sierich, Heidi
Kroeger, Nicolaus
TISSUE ANTIGENS, 2014, 84 (01): : 161 - 162

← 1 2 3 4 5 →